MiR-205 Dysregulations in Breast Cancer: The Complexity and Opportunities

MiR-205 Dysregulations in Breast Cancer: The Complexity and Opportunities

MicroRNAs (miRNAs) are endogenous non-coding small RNAs that downregulate target gene expression by imperfect base-pairing with the 3′ untranslated regions (3′UTRs) of target gene mRNAs. MiRNAs play important roles in regulating cancer cell proliferation, stemness maintenance, tu...

Full description

Bibliographic Details
Main Authors:	Yajuan Xiao, Brock Humphries, Chengfeng Yang, Zhishan Wang
Format:	Article
Language:	English
Published:	MDPI AG 2019-11-01
Series:	Non-Coding RNA
Subjects:	mir-205-5p (mir-205) breast cancer metastatic breast cancer triple negative breast cancer luminal a/b breast cancer her2+ breast cancer
Online Access:	https://www.mdpi.com/2311-553X/5/4/53

Similar Items

miR-205 in Breast Cancer: State of the Art
by: Ilaria Plantamura, et al.
Published: (2021-12-01)

Coix Seed Oil Exerts an Anti–Triple-Negative Breast Cancer Effect by Disrupting miR-205/S1PR1 Axis
by: Ting Fang, et al.
Published: (2020-09-01)

TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
by: Hong-Yu Ma, et al.
Published: (2020-12-01)

Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets
by: Ishita Gupta, et al.
Published: (2020-09-01)

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer
by: Alberto Montero, et al.
Published: (2012-12-01)

Distinct Microbial Signatures Associated With Different Breast Cancer Types
by: Sagarika Banerjee, et al.
Published: (2018-05-01)

Lapatinib and chronic renal insufficiency
by: Luca Moscetti
Published: (2018-03-01)

Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial
by: Shuo Wu, et al.
Published: (2020-05-01)

EXTENDED PROGRESSION-FREE SURVIVAL ON FIRST LINE TREATMENT WITH DOCETAXEL IN PATIENT WITH METASTATIC TRIPLE NEGATIVE BREAST CARCINOMA
by: Sharma, Purva, et al.
Published: (2021)

Imbalance of Molecular Module of TINCR-miR-761 Promotes the Metastatic Potential of Early Triple Negative Breast Cancer and Partially Offsets the Anti-Tumor Activity of Luteolin
by: Zhang ML, et al.
Published: (2021-02-01)

Current approaches in treatment of triple-negative breast cancer
by: Hanan Ahmed Wahba, et al.
Published: (2015-06-01)

Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia
by: Sumadi Lukman Anwar, et al.
Published: (2020-05-01)

A clinicopathologic study of triple negative breast cancer
by: Vandana L Gaopande, et al.
Published: (2015-01-01)

Secretory carcinoma of the breast: A case report and literature review
by: I-Kai Wu, et al.
Published: (2021-01-01)

Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR‐7
by: Chunlei Yuan, et al.
Published: (2020-07-01)

Improved delivery of miR-1296 loaded cationic nanoliposomes for effective suppression of triple negative breast cancer
by: Lamyaa Albakr, et al.
Published: (2021-05-01)

Circ_0000520 contributes to triple‐negative breast cancer progression through mediating the miR‐1296/ZFX axis
by: Yong Zhou, et al.
Published: (2021-09-01)

Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer
by: Abdur R. Shakir
Published: (2014-04-01)

The role and function of SOX11 in DNA damage in triple-negative breast cancer
by: Lee, Tian Yu
Published: (2019)

Characteristics of Patients with Estrogen Receptor (ER)-Negative, Progesterone Receptor (PR)-Negative, and HER2-Negative Invasive Breast Cancer in Dr. Hasan Sadikin General Hospital, Bandung, Indonesia from 2010 to 2011
by: Nadytia Kusumadjayanti, et al.
Published: (2015-09-01)

Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells
by: Shujun Li, et al.
Published: (2020-01-01)

Acid-base transporters and pH dynamics in human breast carcinomas predict proliferative activity, metastasis, and survival
by: Nicolai J Toft, et al.
Published: (2021-07-01)

Role of proteasome system in prognosis of breast cancer progression
by: E. E. Shashova, et al.
Published: (2018-09-01)

Hipoexpressão de miR-205ab e miR-218a associada ao pior prognóstico em pacientes com câncer de mama
by: Paes, Juliana Fracalossi
Published: (2019)

Regulatory Effects of miR-205 on Invasion and Migration of Gastric Cancer Cells and Potential Mechanism
by: WANG Yuxia, et al.
Published: (2018-05-01)

Outcomes After Accelerated Partial Breast Irradiation in Women With Triple Negative Subtype and Other “High Risk” Variables Categorized as Cautionary in The ASTRO Guidelines
by: Anabel Goulding, et al.
Published: (2021-03-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
by: Liu C, et al.
Published: (2020-12-01)

Clinical Initial Response of Neoadjuvant Chemotheraphy in Triple Negative, HER-2, and Luminal Types of Breast Cancer in Denpasar (A Preliminary Study)
by: Kristianto Yuli Yarso, et al.
Published: (2012-01-01)

Clinical Initial Response of Neoadjuvant Chemotheraphy in Triple Negative, HER-2, and Luminal Types of Breast Cancer in Denpasar (A Preliminary Study)
by: Kristianto Yuli Yarso, et al.
Published: (2012-01-01)

Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
by: Sylvia Annabel Dass, et al.
Published: (2021-01-01)

Clinical and histopathological characteristics associated with patients with triple-negative Breast cancer at a national reference hospital, 2012 - 2018
by: Giuliana Mandujano-Guizado, et al.
Published: (2019-06-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Genomic features of rapid versus late relapse in triple negative breast cancer
by: Yiqing Zhang, et al.
Published: (2021-05-01)

Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review
by: Junzo Yamaguchi, et al.
Published: (2021-04-01)

miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer
by: Jie Li, et al.
Published: (2017-11-01)

Breast Cancer Treatments: Updates and New Challenges
by: Anna Burguin, et al.
Published: (2021-08-01)

Combination of Ixabepilone and Capecitabine in Metastatic Triple Negative Breast Cancer. Clinical case
by: E. V. Glazkova, et al.
Published: (2019-12-01)

Overexpression of lncRNA TATDN1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Regulating miR-26b Methylation
by: Long Q, et al.
Published: (2020-11-01)

Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors
by: Abbas Mosapour, et al.
Published: (2020-08-01)

PARP inhibitors in the treatment of metastatic breast cancer patients with germline BRCA1/2 mutations. Experience of treatment with talazoparib in clinical practice
by: M. A. Frolova, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_qiege8kbkl24bring05ps9dj54